Z Factor Overview

  • Founded
  • 2015
Founded
  • Status
  • Private
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $8.87M
Latest Deal Amount
  • Investors
  • 3

Z Factor General Information

Description

Operator of aa a drug discovery company intended to identify therapeutic agents to treat alpha-1-antitrypsin deficiency. The company's activities are focused on designing and developing novel therapeutic agents to correct the misfolding of the Z variant of alpha-1-antitrypsin, thereby addressing an important and unmet medical need where current treatments are limited to lung or liver transplantation and augmentation therapy.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • The Dorothy Hodgkin Building
  • Babraham Research Campus
  • Cambridge CB22 3AT
  • England, United Kingdom
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Z Factor Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 03-May-2017 $8.87M 000.00 000.00 Completed Startup
1. Early Stage VC (Series A) 05-Feb-2015 00.000 00.000 00.000 Completed Startup
To view Z Factor’s complete valuation and funding history, request access »

Z Factor Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 000,000 00.000000 00.00 00.00 00 00.00 00.000
Seed 0,000,000 00.00 00.00 00 00.00 00.000
To view Z Factor’s complete cap table history, request access »

Z Factor Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Operator of aa a drug discovery company intended to identify therapeutic agents to treat alpha-1-antitrypsin deficiency.
Drug Discovery
Cambridge, United Kingdom
000.00
00.00 0000-00-00
00000000000 000.00

00000000

ididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco
0000 000000000
Salt Lake City, UT
000 As of 0000
00000
0.000 0000-00-00
00000000000 00000

00 00000

dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliq
0000 000000000
Guilford, CT
00 As of 0000
0000
000000000 - 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Z Factor Competitors (8)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Recursion Pharmaceuticals Venture Capital-Backed Salt Lake City, UT 000 00000 00000000000 00000
00 000000000000 Venture Capital-Backed Guilford, CT 00 0000 000000000 - 0000
00000000 Angel-Backed Charlottesville, VA 00 000 0000000000 000
000000 00000000000 Corporation Plymouth Meeting, PA 000 000.00 00000000 000.00
0000000 Venture Capital-Backed Toronto, Canada 00 000.00 00000 000.00
You’re viewing 5 of 8 competitors. Get the full list »

Z Factor Executive Team (2)

Name Title Board Seat Contact Info
James Huntington Ph.D Founder & Chief Operating Officer
David Grainger Ph.D Executive Chairman
To view Z Factor’s complete executive team members history, request access »

Z Factor Board Members (3)

Name Representing Role Since
Christine Martin Cambridge Enterprise Board Member 000 0000
David Grainger Ph.D Self Executive Chairman 000 0000
Francesco De Rubertis Ph.D Medicxi Board Member 000 0000
To view Z Factor’s complete board members history, request access »

Z Factor Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Cambridge Innovation Capital Venture Capital Minority 000 0000 000000 0
Medicxi Venture Capital Minority 000 0000 000000 0
Cambridge Enterprise Angel Group Minority 000 0000 000000 0
To view Z Factor’s complete investors history, request access »